RhumbLine Advisers’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-85,928
| Closed | -$98.8K | – | 4271 |
|
|
2025
Q1 | $98.8K | Sell |
85,928
-46,897
| -35% | -$53.9K | ﹤0.01% | 3399 |
|
|
2024
Q4 | $291K | Buy |
132,825
+40,813
| +44% | +$89.4K | ﹤0.01% | 3005 |
|
|
2024
Q3 | $201K | Buy |
92,012
+1,681
| +2% | +$3.66K | ﹤0.01% | 3238 |
|
|
2024
Q2 | $209K | Buy |
90,331
+24,885
| +38% | +$57.5K | ﹤0.01% | 3203 |
|
|
2024
Q1 | $360K | Sell |
65,446
-12,036
| -16% | -$66.2K | ﹤0.01% | 2870 |
|
|
2023
Q4 | $191K | Buy |
77,482
+12,853
| +20% | +$31.7K | ﹤0.01% | 3208 |
|
|
2023
Q3 | $2.24M | Buy |
64,629
+786
| +1% | +$27.3K | ﹤0.01% | 1797 |
|
|
2023
Q2 | $2.09M | Buy |
63,843
+30,952
| +94% | +$1.02M | ﹤0.01% | 1880 |
|
|
2023
Q1 | $1.1M | Buy |
32,891
+2,471
| +8% | +$82.8K | ﹤0.01% | 2077 |
|
|
2022
Q4 | $997K | Buy |
30,420
+2,464
| +9% | +$80.8K | ﹤0.01% | 2129 |
|
|
2022
Q3 | $976K | Buy |
27,956
+2,519
| +10% | +$87.9K | ﹤0.01% | 2144 |
|
|
2022
Q2 | $311K | Buy |
+25,437
| New | +$311K | ﹤0.01% | 2735 |
|